Estradiol Patch
Product Images NDC 50090-7988

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 50090-7988). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estradiol Structural Formula (Image 01)

FDA Label Image

Transdermal Parts (Image 02)

Transdermal Parts (Image 02)
This is a layered structure starting with foam backing with an adhesive layer at the bottom. On top of that is a polyester film layer followed by an acrylate adhesive matrix layer. The top layer consists of a protective liner that contains Estradiol. This structure is likely part of a product that uses these layers for a specific application or functionality.*
FDA Label Image

Figure 1 Mean Serum 17β-estradiol Concentrations Vs. Time Profile Following Application Of A 7.75 Cm2 Transdermal Patch And Application Of A 15.5 Cm2 Estradiol Transdermal System Continuous Delivery (once-weekly) Patch (Image 03)

Figure 1 Mean Serum 17β-estradiol Concentrations Vs. Time Profile Following Application Of A 7.75 Cm2 Transdermal Patch And Application Of A 15.5 Cm2 Estradiol Transdermal System Continuous Delivery (once-weekly) Patch (Image 03)
This text appears to be a representation of a graph showing the time in hours on the x-axis and the legend for Estradiol Transdermal System on the y-axis. It includes different measurements and values related to the system.*
FDA Label Image

Figure 2 Observed Mean (± S.e.) Estradiol Serum Concentrations For A One Week Application Of The Estradiol Transdermal System Continuous Delivery (once-weekly) (31 Cm2) To The Abdomen And Buttocks Of 38 Postmenopausal Women (Image 04)

FDA Label Image

Figure 3 Mean Percent Change From Baseline In Lumbar Spine (a-p View) Bone Mineral Density By Treatment And Time Last Observation Carried Forward (Image 05)

FDA Label Image

Figure 4 Mean Percent Change From Baseline In Total Hip By Treatment And Time Last Observation Carried Forward (Image 06)

FDA Label Image

Instructions For Use Figure A (Image 07)

Instructions For Use Figure A (Image 07)
This text refers to a transdermal system for the continuous delivery of Estradiol. It is designed for once-weekly use. "Figure A" may be a visual representation or illustration related to the product.*
FDA Label Image

Instructions For Use Figures B And C (Image 08)

Instructions For Use Figures B And C (Image 08)
This is a description of a medical procedure involving the removal of an estradiol patch with additional tear notches. The text mentions Figure B and Figure C, suggesting that these are part of a set of instructions or images to guide the process.*
FDA Label Image

Instructions For Use Figures D And E (Image 09)

Instructions For Use Figures D And E (Image 09)
This text mentions information about an Estradiol patch, a hormonal patch used to deliver Estradiol. It appears to show an image or diagram displaying protective inner layers of the patch.*
FDA Label Image

Instructions For Use Figures F And G (Image 10)

FDA Label Image

Instructions For Use Figure H (Image 11)

FDA Label Image

Label Image (Lbl500907988)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.